PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsNicoderm
Nicoderm
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
2238 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Tobacco use disorderD014029F17861194964292577
Smoking cessationD016540EFO_000431939503566250425
SmokingD012907EFO_000431828302034194293
Cigarette smokingD000073865192451398152
Tobacco useD064424Z72.0857295115
Tobacco smokingD0000738695521081101
VapingD00007213776177192
Tobacco use cessationD0203404107115077
SchizophreniaD012559EFO_0000692F207122162963
Substance-related disordersD019966EFO_0003890F1363134962
Show 77 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E1311415
Post-traumatic stress disordersD013313EFO_0001358F43.12111013
AsthmaD001249EFO_0000270J4521912
AnesthesiaD00075811112
Traumatic stress disordersD040921211811
Harm reductionD040261313410
SyndromeD01357711179
Smoking reductionD0000742641168
Postoperative complicationsD011183178
InfectionsD007239EFO_0000544167
Show 38 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients1312740
ObesityD009765EFO_0001073E66.9142126
Breast neoplasmsD001943EFO_0003869C50121922
AnxietyD001007EFO_0005230F41.1131922
Chronic painD05935011617
OverweightD050177E66.32911
Lung diseasesD008171EFO_0003818J98.4189
Psychological distressD0000792253169
CannabisD0021884127
InflammationD007249MP_00018452125
Show 47 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Anxiety disordersD001008EFO_0006788F41.121315
StrokeD020521EFO_0000712I63.91910
CarcinomaD002277C80.0189
Prostatic neoplasmsD011471C61167
Autism spectrum disorderD000067877F84.0156
EmergenciesD004630145
HemorrhageD006470MP_0001914R58145
Periodontal diseasesD010510K05.6145
PeriodontitisD010518EFO_0000649K05.3134
AggressionD000374EFO_0003015134
Show 31 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I101212
Acceptance and commitment therapyD06486999
Type 2 diabetes mellitusD003924EFO_0001360E1199
Sedentary behaviorD05718599
Wounds and injuriesD014947T14.888
Chronic diseaseD00290877
HypoxiaD000860R09.0277
ApneaD001049R06.8177
Communicable diseasesD00314155
Heart disease risk factorsD00008274255
Show 340 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
16,715 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use